CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-13 | SAYER KEVIN R Chairman, CEO & President | Sale | −417 | $357.24 | $149K | 144,809 |
| 2021-01-13 | SAYER KEVIN R Chairman, CEO & President | Sale | −407 | $359.79 | $146K | 144,402 |
| 2021-01-12 | SAYER KEVIN R Chairman, CEO & President | Sale | −428 | $359.68 | $154K | 190,996 |
| 2021-01-12 | SAYER KEVIN R Chairman, CEO & President | Sale | −39,521 | $362.12 | $14.3M | 151,475 |
| 2021-01-08 | SAYER KEVIN R Chairman, CEO & President | Grant or award | +75,910 | 191,424 | ||
| 2021-01-06 | AUGUSTINOS NICHOLAS Director | Sale | −625 | $375.00 | $234K | 11,967 |
| 2021-01-04 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −27 | $362.96 | $10K | 32,522 |
| 2021-01-04 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −28 | $365.16 | $10K | 32,494 |
| 2021-01-04 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −10,970 | $366.07 | $4.0M | 21,524 |
| 2020-12-29 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Gift | −950 | 32,549 | ||
| 2020-12-28 | Murphy Patrick Michael EVP, Chief Legal Officer | Sale | −500 | $355.39 | $178K | 19,078 |
| 2020-12-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −257 | $357.95 | $92K | 60,603 |
| 2020-12-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −292 | $358.94 | $105K | 60,311 |
| 2020-12-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −210 | $359.98 | $76K | 60,101 |
| 2020-12-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −153 | $361.11 | $55K | 59,948 |
| 2020-12-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −87 | $361.99 | $31K | 59,861 |
| 2020-12-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −60 | $364.00 | $22K | 59,801 |
| 2020-12-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −20 | $364.68 | $7K | 59,781 |
| 2020-12-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −120 | $357.31 | $43K | 10,973 |
| 2020-12-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −265 | $358.48 | $95K | 10,708 |
Page 43 of 55 · 1,082 trades